Search

You searched for "age"

1684 results found

My top five: Influential ophthalmologists

4 October 2023 | | Ophthalmology
Ophthalmology has witnessed remarkable evolution and advancements throughout history. The field has undergone dramatic change and development since the times of Ancient Egypt where the first reference to eyes was made in the Code of Hammurabi (2250 BC) [1]. From...

Caring for adults with an ocular tumour

1 December 2015 | | Retina / Uvea / Vitreous
Detection If you screen for an intraocular tumour, dilate the pupil. If the patient is driving, use phenylephrine only. If the patient declines, document this in the casenotes. Don’t forget to look for sentinel vessels, which would indicate a ciliary...

Vitreous loss fire drills – ophthalmic simulation improves trainee surgical competence and confidence with posterior capsule rupture scenarios

4 December 2023 | | Cataract and Refractive
Ophthalmic trainees have reported limited exposure and low confidence regarding the management of cataract complications such as posterior capsule rupture (PCR) / vitreous loss (VL). This report evaluates the impact of a simulation-based educational training event on these concerns. Introduction...

VISION 2020 LINKS Programme and DR-NET World Sight Day Workshop

7 December 2020 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, COVID-19, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Optometry, Orbit, Ophthalmology, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
World Sight Day (WSD) was celebrated globally on 8 October 2020 [1]. From Australia and the Pacific to the Americas, via Asia, Africa and the Caribbean, awareness-raising and advocacy activities took place throughout the day, to focus attention on unnecessary...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

1 October 2018 | | Ophthalmology
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...

Cutting-edge practice in glaucoma care: what, how and why?

1 April 2016 | | Glaucoma
More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...

What’s next in retinal imaging? Faster, deeper and full-on

1 April 2015 | | Retina / Uvea / Vitreous, Imaging
Fast-evolving technological leaps are opening the way toward clinically useful ocular coherence angiography, generating 3-dimensional microvasculature maps without intravenous dye injection, as well as whole-eye imaging, handheld patient-operated optical coherence tomography (OCT) devices and, for challenging vitreoretinal procedures, integrated intraoperative...

Contemporary glaucoma therapy: spoilt for choice

1 April 2014 | | Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Eye Capacity: clinical need should drive ophthalmic service provision

1 February 2014 |
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

The management of retinal vein occlusions: a summary

1 February 2015 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Imaging, Ophthalmology, Retina / Uvea / Vitreous
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...

Code-Free Deep Learning: a step into the future of ophthalmology

3 October 2022 | | Ophthalmology
A new focus has arisen within the research domain of artificial intelligence (AI) in healthcare called code-free deep learning (CFDL), and recent research demonstrates that ophthalmology is becoming one of the leading specialties in this field. Artificial intelligence (AI) is...

The bionic eye – behind the headlines

1 October 2016 | | Oculoplastics, Orbit
Multiple visual prosthetic projects and other vision regeneration initiatives being tested in preclinical and clinical development worldwide illustrate continuing progress and opportunities in addressing profound blindness from hereditary retinal diseases and other causes (Table 1). Three implantable bionic vision systems...